8-KFinancial EventsRegulation FDExhibits & Filings

CVS HEALTH Corp 8-K Report, Material Impairment (Nov 18, 2021)

Filed November 18, 2021For Securities:CVS

Summary

CVS Health Corporation (CVS) announced a significant strategic shift impacting its retail operations through an 8-K filing on November 18, 2021. The company plans to close approximately 900 stores over the next three years, with about 300 closures expected annually. This decision stems from a strategic review of the retail business, aimed at adapting to changing consumer behaviors, population shifts, and future health needs by creating new store formats and optimizing locations. This initiative is expected to result in an estimated non-cash impairment charge of $1.0 billion to $1.2 billion, primarily related to operating lease right-of-use assets and property and equipment. These charges are anticipated to be recorded in the fourth quarter of 2021. The company also indicated that a large percentage of affected employees are expected to be offered alternative roles. This filing also referenced an updated full-year 2021 guidance, though specific details were provided in a press release.

Key Highlights

  • 1CVS Health to close approximately 900 retail stores over the next three years (around 300 per year).
  • 2Store closures are part of a strategic review to adapt to changing consumer patterns and optimize store formats and locations.
  • 3Estimated non-cash impairment charges of $1.0 billion to $1.2 billion are expected, primarily for the fourth quarter of 2021.
  • 4Charges relate to impairment of operating lease right-of-use assets and property and equipment.
  • 5A significant portion of affected store employees are expected to be offered new roles within the company.
  • 6The company updated its full-year 2021 guidance, with details provided in a separate press release.

Frequently Asked Questions

CVS Health is closing stores as part of a strategic review of its retail business. The aim is to adapt to changing consumer buying patterns, population shifts, and evolving future health needs by optimizing store locations and formats to better serve customers and the business.

The company estimates total non-cash impairment charges of approximately $1.0 billion to $1.2 billion. These charges are expected to be recorded in the three months and year ending December 31, 2021, and relate primarily to the impairment of operating lease right-of-use assets and property and equipment.

CVS Health expects that a large percentage of the colleagues employed at the impacted stores will be offered roles in other locations or different opportunities within the company.

Yes, the company updated its full-year 2021 guidance. This information was shared in a press release dated November 18, 2021, which was furnished as an exhibit to this 8-K filing.